According to the latest report by IMARC Group, the United States biologics market was valued at USD 190.3 Billion in 2024 and is projected to reach USD 371.0 Billion by 2033, growing at a CAGR of 7.4% during 2025–2033. The market is witnessing strong momentum due to rapid advancements in biotechnology, increasing chronic disease burden, and the integration of artificial intelligence (AI)...